No Data
No Data
No Data
No Data
No Data
Sector Update: Health Care Stocks Mixed Wednesday Afternoon
Health care stocks were mixed in Wednesday afternoon trading, with the NYSE Health Care Index fractionally higher and the Health Care Select Sector SPDR Fund (XLV) slightly lower. The iShares Biotechn
MT NewswiresApr 17 13:46 ET
NeuroBo Begins Dosing in Phase 1 Study of Obesity Treatment; Shares Rise
NeuroBo Pharmaceuticals (NRBO) said Wednesday the first patient has been dosed in part 1 of its two-part early-stage trial of DA-1726 for the treatment of obesity. The company said part 1 of the study
MT NewswiresApr 17 11:21 ET
Express News | NeuroBo Pharmaceuticals Doses First Patient In Phase 1 Clinical Trial Evaluating DA-1726 For Treatment Of Obesity
Moomoo 24/7Apr 17 08:06 ET
Express News | NeuroBo Pharmaceuticals Inc - First Patient Dosed in Multiple Ascending Dose Part 2 Expected in Q3 of 2024
Moomoo 24/7Apr 17 08:05 ET
Express News | NeuroBo Pharmaceuticals Inc - Top-Line Data Readout From Single Ascending Dose Part 1 Now Expected in Q3 of 2024
Moomoo 24/7Apr 17 08:05 ET
Express News | NeuroBo Pharmaceuticals Doses First Patient in Its Phase 1 Clinical Trial Evaluating Da-1726 for the Treatment of Obesity
Moomoo 24/7Apr 17 08:05 ET
No Data
No Data